Falling Walls 2024. Science Breakthroughs of the Year 2024 | Pitches
Falling Walls 2024. Science Breakthroughs of the Year 2024 | Pitches ActiTrexx has been awarded the main prize in the Science Start-Ups category. The [...]
SAT.1 Regionalmagazin features ActiTrexx GmbH as an example for a biotech start-up in Rhineland-Palatinate.
ActiTrexx GmbH was featured in SAT.1 Regionalmagazin as an example for a biotech start-up in Rhineland-Palatinate. Guest in the studio: The biotechnology commissioner of [...]
ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease
Mainz, Germany, 19 March 2024 – ActiTrexx GmbH, a clinical-stage company focusing on the activation of regulatory T cells, has treated the first patient with [...]
Pioniergeist Preisverleihung 2022
ActiTrexx erhält den mit 15.000 Euro dotierten ersten Preis für die Entwicklung der „ATreg“ Zelltherapie. Read more: https://isb.rlp.de/aktuelles/news/detailansicht/nachbericht-pioniergeist-preisverleihung-2022.html [...]
Newly founded biotech company ActiTrexx receives funding of € 3.5 million to develop cell therapy against transplant rejection
As the first company, alongside the Life Science Factory team, we moved to the new Sartorius quarter on Weender Landstrasse on January 1st, 2022. [...]